Anfield Capital Management »

Immunome shares owned by Anfield Capital Management

Quarter-by-quarter ownership of Immunome (IMNM) shares owned by Anfield Capital Management from 13F filings

Historical chart of Anfield Capital Management investment in Immunome

Tip: Access up to 7 years of quarterly data

All positions including Immunome held by Anfield Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunome by Anfield Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $299k 14k 21.87

More positions owned by Anfield Capital Management

Ss Spdr S&p 500 Etf Trust-us Tr Unit (SPY)
Ss Comm Select Sector Spdr State Street Com (XLC)
Ishares Semiconductor Etf Ishares Semicdtr (SOXX)
Anfield Us Equity Sector Rot Anfield Us Equ (AESR)
Ishares Mbs Etf Mbs Etf (MBB)
Ark Next Generation Internet Next Gnrtn Inter (ARKW)
Ishares Us Pharmaceuticals E U.s. Pharma Etf (IHE)
Ishr Ibx Usd Invgd Cb Etf-ui Iboxx Inv Cp Etf (LQD)
Wisdomtree Japan Hedged Eq Japn Hedge Eqt (DXJ)
Invesco S&p Midcap Value Wit S&p Mdcp Vlu Mnt (XMVM)
Ishares Us Treasury Bond Etf Us Treas Bd Etf (GOVT)
Janus Henderson Aaa Clo Etf Hendrson Aaa Cl (JAAA)
Ss Industrial Select Sector State Street Ind (XLI)
Avantis Us Small Cap Value Us Sml Cp Valu (AVUV)
Ishares Morningstar Small-ca MRGSTR SM CP GR (ISCG)

View all positions for Anfield Capital Management

Top funds holding Immunome

FMR
T. Rowe Price Investment Management
BlackRock
Vanguard Group
Redmile Group
PRIMECAP Management Company
Vanguard Capital Management
State Street Corporation
Driehaus Capital Management
Enavate Sciences GP
Morgan Stanley
Geode Capital Management
Leucadia National Corporation
Sofinnova Ventures
Woodline Partners

View all funds holding Immunome